We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Eltrombopag Plus Granulocyte Colony-stimulating Factor (G-CSF) on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant (ASCT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01286675
Recruitment Status : Active, not recruiting
First Posted : January 31, 2011
Last Update Posted : January 19, 2018
Information provided by (Responsible Party):
Nancy Berliner, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2018